PPARG and cancer: Similarly, Li et al. treated the endometrial cancer cell lines HHUA, Ishikawa, and HEC-59, with the PPARγ ligand 15-Deoxy-Δ12,14-prostaglandin J2 and reported significant growth inhibitory and apoptotic effects in all three studied cancer cell lines.